PCG Molecular is the leading provider in cutting-edge, preventive genetic screenings.

Pioneering Preventive Cancer Screening Through Molecular Diagnostics

PCG Molecular is dedicated to the research and development of genetic screens that detect early signs of DNA and cellular damage that can lead to health risks. The tests are easy to administer, often covered by health insurance and non-invasive to the patient.

Why Test? Take a look at Oral Cancer Statistics Alone

Total Cancer Diagnoses This Year:

The National Cancer Institute reports that 40% of those diagnosed with oral cancer will die within five years. Why? Because it's typically discovered in late stage.

24 lives per day

Someone dies every hour from oral cancer. Most are preventable if found early.

3x greater risk

Oral cancer has an incidence rate that is three times greater than cervical cancer.

30 seconds

That's all it takes to protect yourself or someone you love. It couldn't be easier.

Who We Serve

Reinventing health care means giving patients and doctors the information they need to make good decisions and decreases risks. PCG Molecular gives you the tools to do just that.

Serving Patients

  • > Schedule annual appointments
  • > Take a simple oral rinse or PAP
  • > Know if you're at risk
  • > Become aware before there's a problem

Serving Practitioners

  • > Implement proactive business models
  • > Administer tests without disruption
  • > Communicate positive results
  • > Practice proactive versus reactive care

Our Approach

The PCG Experience

PCG Molecular establishes robust communication channels for doctors and patients. Patients receive information throughout the process that answers pre-test concerns, post-test results and additional actions that may need to be taken.
Our proprietary business model addresses the needs of patients while incorporating ways to grow the practice. PCG Molecular is a true partner, leading the way to better preventive care measures for both patient and practitioner.
Pre-test communications coupled with less invasive procedures increases the number of people who embrace regular, annual testing. Our communication program takes the burden of patient education off your staff.
In addition to our patient communication program, PCG Molecular also provides marketing support and business revenue models to benefit your practice, not burden it.

Products

Get the MOP™

The MOP is the only comprehensive, genetic oral cancer screening test on the market.

The MOP test detects oral cancer and precursors to oral cancer much earlier than any other test available.  It is a simple minty mouth wash.  You swish and gargle it for 30 seconds and spit it back in a cup.  It’s that simple and it could save your life.  All adults aged 18 and older should be screened annually.

The MOP is the only test available that detects all three signs of potential cancer, including cell abnormalities, Human Papilloma Virus (HPV), and DNA damage.

Get the MAP™

Why is the MAP better? Typically doctors screen for anal cancer through a test known as the DRE (Digital Rectal Exam). It’s invasive, may not catch things higher in the anal cavity and there is room for human error. The Molecular Anal PAP is a much less invasive and more accurate procedure.

While HPV is the leading cause of anal cancer, there are other forms. There is a known heredity component and other factors like your age or DNA can play a role. The MAP not only shows whether you have anal cancer, but also if your in a higher risk category to contract it. It’s an innovative genetic test that screens for anal cancer and its risk factors in three ways:

  • Cell Abnormalities
  • HPV (Human Papilloma Virus)
  • DNA Damage
"We aspire to help change national figures around virus and disease through early intervention, well identified warning signs, and preventive measures."
-Armando Moncada,
MD FCAP
Founder/CEO